Flatiron Health reviews

Internal mobility has mostly ceased. No backfill for attrition. Perks were slashed in 2023 (no more professional development budget, cell reimbursement or gym/lifestyle fund) and layoffs have been made. As of April 26th we got a generic “Roche wants us to tighten the budget” email again with another update to come May 10th. Lack of transparency has become the norm, as well as the threat of looming layoffs.

There's no way to sugarcoat it. Flatiron probably has a year, maybe two, of viable operation left. It's not entirely clear what's going to happen next, but there's no chance left of it being good. It operates massively in the red, can't raise, can't grow fast enough to close the gap in time, and is right in the crosshairs of its cash-strapped and beleaguered parent company. If you're here now, treasure every moment with your colleagues that you can while you quickly, but calmly, start moving towards the door. If you're considering coming here, reconsider. If you have no other good options, then you'll be rewarded by some really lovely colleagues and challenging, interesting work. But that could all change or go away at any time, and it appears that it may do so quite soon.